Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc. (ISRG)

Market Closed
23 Feb, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
492. 10
-11.95
-2.37%
$
179B Market Cap
76.32 P/E Ratio
- Div Yield
1,763,823 Volume
5.59 Eps
$ 504.05
Previous Close
Day Range
486.45 502.7
Year Range
425 603.88
Want to track ISRG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ISRG earnings report is expected in 55 days (20 Apr 2026)
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Zacks | 4 weeks ago
ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines

ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines

Intuitive Surgical stock gains after Q4 EPS and revenue top estimates as system placements and procedure growth offset a decline in gross margin.

Zacks | 1 month ago
Intuitive Surgical Just Proved the Growth Engine Still Runs

Intuitive Surgical Just Proved the Growth Engine Still Runs

Robotic-assisted surgery stalwart Intuitive Surgical NASDAQ: ISRG blew investors away with its Q3 2025 earnings report back in October 2025. Shares closed up nearly 14% in reaction to the results, marking the healthcare stock's largest single-day post-earnings gain in recent memory.

Marketbeat | 1 month ago
Intuitive Surgical (ISRG) Reports Q4 Earnings: What Key Metrics Have to Say (Revised)

Intuitive Surgical (ISRG) Reports Q4 Earnings: What Key Metrics Have to Say (Revised)

Although the revenue and EPS for Intuitive Surgical (ISRG) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 month ago
More Upside For ISRG Stock?

More Upside For ISRG Stock?

Intuitive Surgical reported strong Q4 2025 outcomes with adjusted EPS of $2.53, exceeding estimates of $2.26 and increasing by 14.5% from Q4 2024's $2.21. Revenue reached $2.87 billion, a 19% increase year-over-year that surpassed the consensus of $2.75 billion, while full-year revenue hit $10.1 billion (+21%) coupled with adjusted EPS of $8.93.

Forbes | 1 month ago
Intuitive Surgical (ISRG) Reports Q4 Earnings: What Key Metrics Have to Say

Intuitive Surgical (ISRG) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Intuitive Surgical (ISRG) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 month ago
Intuitive Surgical, Inc. (ISRG) Q4 2025 Earnings Call Transcript

Intuitive Surgical, Inc. (ISRG) Q4 2025 Earnings Call Transcript

Intuitive Surgical, Inc. (ISRG) Q4 2025 Earnings Call Transcript

Seekingalpha | 1 month ago
Intuitive Surgical, Inc. (ISRG) Q4 Earnings Surpass Estimates

Intuitive Surgical, Inc. (ISRG) Q4 Earnings Surpass Estimates

Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.53 per share, beating the Zacks Consensus Estimate of $2.25 per share. This compares to earnings of $2.21 per share a year ago.

Zacks | 1 month ago
Intuitive Surgical beats quarterly estimates on demand for surgical robots

Intuitive Surgical beats quarterly estimates on demand for surgical robots

Intuitive Surgical on Thursday beat Wall Street estimates for fourth-quarter profit and revenue on growing demand for ​its surgical robots used in minimally invasive procedures.

Reuters | 1 month ago
ISRG vs. MDT: Which MedTech Stock Is a Better Bet Now?

ISRG vs. MDT: Which MedTech Stock Is a Better Bet Now?

Intuitive Surgical's pure-play robotics focus, rising da Vinci 5 utilization and 85% recurring revenues tilt the risk-reward versus diversified Medtronic.

Zacks | 1 month ago
Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now?

Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now?

ISRG heads into Q4 earnings with 18% procedure growth and da Vinci 5 demand, but valuation and tariffs keep the earnings outlook uncertain.

Zacks | 1 month ago
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results

Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results

ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, margins and outlook.

Zacks | 1 month ago
Loading...
Load More